Freshpet, Inc. to Report Third Quarter 2024 Results on Monday, November 4, 2024

SECAUCUS, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) — Freshpet, Inc. (Nasdaq: FRPT) (“Freshpet” or the “Company”) today announced it will report results for the third quarter ended September 30, 2024 on Monday, November 4, 2024 before market open. The Company will host a conference call with members of the executive management team to discuss these […]

Advanced Flower Capital Schedules Third Quarter 2024 Earnings Conference Call for November 13, 2024

WEST PALM BEACH, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) — AFC Gamma, Inc. (Nasdaq:AFCG) (“Advanced Flower Capital” or “AFC”) today announced that it plans to report earnings for the quarter ended September 30, 2024 on Wednesday, November 13, 2024. Advanced Flower Capital will host a conference call at 10:00 am Eastern Time on Wednesday, November

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

MARIETTA, Ga., Oct. 14, 2024 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2024 after the market close on Wednesday, October 30, 2024. The MIMEDX senior management team will host a webcast and

Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

ADELAIDE, Australia and CAMBRIDGE, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that the Company has been invited to present at

HeartFlow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024

Long-term outcomes data from ADVANCE-DK Registry with HeartFlow FFRCT and Plaque Analysis and ongoing clinical studies highlighting CCTA and FFRCT diagnostic pathway to be discussed in six presentations New data build upon the growing body of clinical evidence supporting non-invasive FFRCT technology and plaque analysis in the diagnosis and management of coronary artery disease MOUNTAIN

Freshworks to Announce Third Quarter 2024 Financial Results on November 6, 2024

SAN MATEO, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH) will announce its financial results for the third quarter ended September 30, 2024 following the close of market on Wednesday, November 6, 2024. Freshworks will host a live audio webcast beginning at 2:00 p.m Pacific Time / 5:00 p.m. Eastern Time that

MKS Instruments Announces Third Quarter 2024 Earnings Conference Call

ANDOVER, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release third quarter 2024 financial results after market close on Wednesday, November 6, 2024. A conference call with management will be held on Thursday, November 7,

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status ofCommon Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Oct 07, 2024 to Oct 11, 2024 AMSTERDAM – October 14, 2024 — STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase

MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6

MDxHealth to Present Third Quarter 2024 Financial Resultsand Corporate Update on November 6 Company to Host Conference Call with Live Q&A, November 6, 2024, at 4:30pm ET / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – October 14, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a commercial-stage precision diagnostics company, today announced it will release

Mari Hoidal joins Avails Medical as Vice President of Marketing

Avails Medical, Inc., a pioneer in accelerating antibiotic susceptibility testing (AST) solutions, is proud to announce the appointment of Mari Hoidal as Vice President of Marketing. With over 20 years of experience in healthcare and diagnostics marketing, Mari brings a wealth of expertise in developing and executing global marketing strategies. Mari Hoidal joins Avails Medical,

Scroll to Top